HIP
REGN icon

HUB Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

HUB Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
2,079
+899
+76% +$612K 0.02% 389
2026
Q1 		$912K Buy
1,180
+839
+246% +$642K 0.02% 386
2025
Q4 		$263K Buy
+341
New +$232K 0.01% 717

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HUB Investment Partners's REGN Position: Q2 2026 in Review

HUB Investment Partners increased its Regeneron Pharmaceuticals (REGN) stake by 76% in Q2 2026, buying an estimated $612K and bringing the position to 2,079 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #389.

HUB Investment Partners first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • HUB Investment Partners held 2,079 shares of Regeneron Pharmaceuticals worth $1.3M as of Q2 2026.
  • HUB Investment Partners bought 899 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $612K.
  • Regeneron Pharmaceuticals made up 0.02% of HUB Investment Partners's portfolio in Q2 2026, its #389 holding.
  • HUB Investment Partners first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.